Showing 2391-2400 of 5617 results for "".
Redefining Aesthetic Aging Through Cellular Medicine
https://reachmd.com/ma-issues-index/jan-feb-2026-issue/redefining-aesthetic-aging-through-cellular-medicine/54431/Growth Factors as a Cornerstone in Cost-Effective Regenerative Medicine
https://reachmd.com/ma-issues-index/jan-feb-2026-issue/growth-factors-as-a-cornerstone-in-cost-effective-regenerative-medicine/54432/Reimagining Menopause with Hormones and Longevity
https://reachmd.com/ma-issues-index/jan-feb-2026-issue/reimagining-menopause-with-hormones-and-longevity/54435/Managing Unexpected Aesthetic Changes Associated with the Use of GLP-1 Receptor Agonists
https://reachmd.com/ma-issues-index/jan-feb-2026-issue/managing-unexpected-aesthetic-changes-associated-with-the-use-of-glp-1-receptor-agonists/54441/The Regenerative Potential of Extracellular Vesicles in Aesthetic Medicine
https://reachmd.com/ma-issues-index/jan-feb-2026-issue/the-regenerative-potential-of-extracellular-vesicles-in-aesthetic-medicine/54436/The Impact of Zero in Rheumatology
https://reachmd.com/programs/medical-industry-feature/the-impact-of-zero-in-rheumatology/32264/Most patients with psoriatic arthritis, non-radiographic axial spondyloarthritis, and ankylosing spondylitis have symptoms across multiple domains.1-2 In fact, when patients meet certain outcome measures, like ACR50 or ASAS40, they may still have active disease that disrupts everyday life.3-5 And paHow COVID-19 mRNA Vaccination Restores Sensitivity to Immune Checkpoint Inhibitors
https://reachmd.com/programs/clinicians-roundtable/covid-19-vaccination-immune-checkpoint-inhibitors/48832/Analyzing the Clinical Evidence
https://reachmd.com/topics/sponsored-articles/analyzing-the-clinical-evidence/49015/Selecting First-Line Therapy in Gastric Cancers: A Biomarker-Driven Approach
https://reachmd.com/programs/project-oncology/selecting-first-line-therapy-in-gastric-cancers-a-biomarker-driven-approach/35505/Testing for biomarkers like PD-L1, HER2, claudin 18.2, and FGFR2b is reshaping our approach to first-line therapy in advanced gastric and gastroesophageal junction cancers. Alongside biomarker profiling, we must also weigh practical considerations around efficacy, toxicity, and patient-specific factCan Prescription Hyperhidrosis Treatments Help Mitigate Symptoms?
https://reachmd.com/topics/rare-disease/can-prescription-hyperhidrosis-treatments-help-mitigate-symptoms/39997/